$BFLY

Butterfly Network, Inc.

3
0
0
—
$1.2M
DEVIVO JOSEPH
40%
See all $BFLY insider activity →
Med

W.P. Carey, Eldorado, GEHC, BFLY, PG&E Trending With Analysts

Analysts have issued ratings for five stocks: W. P. Carey (WPC) received a Buy rating with a $73 target, citing restructuring and sector valuation. Eldorado Gold (EGO) was upgraded to Buy with a $54 target, highlighting growth prospects. GE Healthcare (GEHC) got a Buy rating with a $93 target, expecting growth in imaging and software. Butterfly Network (BFLY) was rated Buy with a $10 target, citing its ultrasound technology.

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

BFLY sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning BFLY (Butterfly Network, Inc.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.

Recent BFLY coverage spans financial news, technology and insider activity.

In the last 30 days, BFLY insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($1.2M). The most active reporter was DEVIVO JOSEPH, President & CEO, with 2 filings. 40% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving BFLY

AlphAI scores every news story that mentions BFLY with an AI model for sentiment and relevance, and aggregates insider trades from Butterfly Network, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BFLY

Score
$WPCMed

W.P. Carey, Eldorado, GEHC, BFLY, PG&E Trending With Analysts

Analysts have issued ratings for five stocks: W. P. Carey (WPC) received a Buy rating with a $73 target, citing restructuring and sector valuation. Eldorado Gold (EGO) was upgraded to Buy with a $54 target, highlighting growth prospects. GE Healthcare (GEHC) got a Buy rating with a $93 target, expecting growth in imaging and software. Butterfly Network (BFLY) was rated Buy with a $10 target, citing its ultrasound technology.

$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong

Butterfly Network (BFLY) Is Down 9.5% After Exclusive Brain-Computer Interface Chip Licensing Deal

Butterfly Network (BFLY) shares fell 9.5% after announcing a multi-year licensing deal with Merge Labs for its Poseidon Family Ultrasound-on-Chip technology. The agreement grants Merge exclusive access for brain-computer interface applications, with Butterfly eligible for upfront, milestone, and royalty payments. The company projects $206.0 million revenue and $25.0 million earnings by 2029, requiring 22.5% yearly revenue growth. Analysts note potential upside but highlight risks including heavy

Related tickers